Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Danielle N. DiTirro"'
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0154874 (2016)
Idiopathic pulmonary fibrosis (IPF) is a progressive, debilitating disease for which two medications, pirfenidone and nintedanib, have only recently been approved for treatment. The cytokine TGF-β has been shown to be a central mediator in the disea
Externí odkaz:
https://doaj.org/article/38055d636c7843c8825acf55b31e768b
Autor:
Stefen A Boehme, Karin Franz-Bacon, John Ludka, Danielle N DiTirro, Tai Wei Ly, Kevin B Bacon
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0167169 (2016)
Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation and lung inflammation resulting in a progressive decline in lung function whose principle cause is cigarette smoke. MAP3K19 is a novel kinase expressed pre
Externí odkaz:
https://doaj.org/article/95344ca64b304d05af4f2cf8aefbe57d
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 5, p e0154874 (2016)
PLoS ONE, Vol 11, Iss 5, p e0154874 (2016)
Idiopathic pulmonary fibrosis (IPF) is a progressive, debilitating disease for which two medications, pirfenidone and nintedanib, have only recently been approved for treatment. The cytokine TGF-β has been shown to be a central mediator in the disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab6eb3b243642ad58a61a8ebd029da27
http://europepmc.org/articles/PMC4856290
http://europepmc.org/articles/PMC4856290
Publikováno v:
Journal of Thoracic Oncology. 12:S1152-S1153
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd26cab149a1bd3a927984d3b1d3b9eb
https://doi.org/10.1016/j.jtho.2016.11.1620
https://doi.org/10.1016/j.jtho.2016.11.1620